Undisclosed

Dianomi Therapeutics will work with Ligand on a medication delivery platform based on research from University of Wisconsin-Madison initially targeting pain disorders and osteoarthritis.

IP Group returned to join corporates BP and Drax for the Leeds CO2 capture spinout’s latest round, taking its total investment in the company to $2.2m since 2009.

The funding takes Istesso’s latest round to $13m as the company continues clinical trials on an immunometabolic drug licensed from an Aberdeen spinout in 2007.

US-based Blue Water Vaccines has an option on University of Oxford research into a universal influenza shot and is looking to raise $15m in funding.

Cambridge-founded automated cell analytics platform Sphere Fluidics has added $2m of funding, bringing its lifetime haul to $14.9m.

Osage University Partners has put up additional capital for oil and gas fluids monitor developer Seismos, which was founded by students from University of Texas.

ICL vascular implant spinout Veryan Medical has been bought by medical device firm Otsuka after raising $56m from investors including IP Group.

Higher education investment fund University Ventures is to invest in its own startup.

Futurelearn, a platform free-to-access Massive Open Online Courses (MOOCs), has been launched by a consortium of UK-based universities, led by distance-learning provider The Open University (OU).

Invesco Perpetual, the fund manager, and Imperial Innovations, the London Stock Exchange-listed spin-off from Imperial College London, are joined by The Cancer Prevention and Research Institute of Texas and the Wellcome Trust supporting Cell Medica's growth.